• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Spring Daylight Savings Transition Tied to Increase in Cardiovascular Events

Medically reviewed by Carmen Pope, BPharm. Last updated on March 14, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, March 14, 2024 -- Spring daylight saving time (DST) transitions may be associated with a minor increase in adverse cardiovascular event rates, according to a study published online in the February issue of Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

Benjamin A. Satterfield, M.D., Ph.D., from the Mayo Clinic in Rochester, Minnesota, and colleagues examined the association of DST transitions with the rates of adverse cardiovascular events using U.S. administrative claims data from roughly 36.1 million individuals.

The researchers found an average increase of 3 and 4 percent in adverse cardiovascular event rates during Monday and Friday of the spring DST transition, respectively. There was less than a 6 percent probability for Monday and Friday and less than a 1 percent probability for the remaining days of this transition being associated with a moderate-to-large increase in the event rates (estimate event rate ratio, >1.10). The probability of any decrease in adverse cardiovascular event rates was estimated to be less than 46 percent for the autumn DST transition, and the probability of a moderate-to-large decrease in the event rates was less than 4 percent across all days. When adjusting by age, results were similar.

"Our findings suggest that DST transitions are unlikely to meaningfully impact the rate of cardiovascular events," the authors write.

One author disclosed a patent for the identification and quantification of group A Streptococcus nucleic acids.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.